Last updated: 2026-09-15 12:10:40. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Forte Biosciences, Inc. (FBRX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $77.00, with a market capitalization of $1.63B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $10.11 to $77.20. This page covers its latest market performance, valuation, price trends and company information.
$1.63B | |
$76.97 | |
$1,349.75 | |
$4.11 | |
$76.97 | |
1.36M | |
-- | |
-- | |
$77.20 | |
$10.11 | |
-- | |
-- |
Forte Biosciences, Inc. (FBRX) is trading at $-- in pre-market trading as of 2026-08-26 23:31:00, -- from the previous close of $76.97
Pre-market trading shows how investors are pricing FBRX before the regular session opens. The current pre-market price is -- the previous close, indicating -- early trading sentiment.
Over the past seven days, Forte Biosciences, Inc. (FBRX) moved from $76.94 to $77.00, representing a gain of 0.07% ($0.06).
The stock traded between $76.82 and $77.00 during the period. The latest price is near the upper end of the 7-day range, indicating range-bound.
The average daily volume was 2.34 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 99.7%
FBRX is currently trading at $77.00, placing it 99.7% of the way from its 52-week low of $10.11 to its 52-week high of $77.20. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Forte Biosciences Inc is a clinical-stage biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications. The Company is also advancing clinical development of FB102 in patient-based trials for non-segmental vitiligo and alopecia areata.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 23 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Forte Biosciences, Inc. (FBRX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.